UPDATE 6-U.S. advisers recommend Human Genome lupus drug

* Shares of Human Genome, partner Glaxo, rise after hours (Rewrites lead, adds panel member, company comments; updates shares)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.